卵巢储备对无精子症患者接受体外受精治疗妊娠结局的影响

IF 3.5 2区 医学 Q1 OBSTETRICS & GYNECOLOGY Reproductive biomedicine online Pub Date : 2024-11-01 Epub Date: 2024-12-04 DOI:10.1016/j.rbmo.2024.104590
Aycan Sıkı , Can Köse , Esin Kasap , Ebru Şahin Güleç , Ahmet Demir
{"title":"卵巢储备对无精子症患者接受体外受精治疗妊娠结局的影响","authors":"Aycan Sıkı ,&nbsp;Can Köse ,&nbsp;Esin Kasap ,&nbsp;Ebru Şahin Güleç ,&nbsp;Ahmet Demir","doi":"10.1016/j.rbmo.2024.104590","DOIUrl":null,"url":null,"abstract":"<div><h3>Objective</h3><div>Infertility is a condition that has been increasingly prevalent in recent years and has demographic, psychological, economic, and medical consequences in society. A review of the literature reveals a large number of studies conducted on azoospermia (AZO) and diminished ovarian reserve (DOR), but there are relatively few studies comparing these two conditions simultaneously. In our study, we aimed to contribute to the literature by comparing these two challenging groups that we treat in our clinic, both from the physician's and the patient's perspective.</div></div><div><h3>Materials and Methods</h3><div>In our study, patients diagnosed with azoospermia (AZO) and diminished ovarian reserve (DOR) who received intracytoplasmic sperm injection (ICSI) treatment at the Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, IVF Center, between January 1, 2017, and June 30, 2023, were examined. Within the inclusion and exclusion criteria, 100 cases were identified and divided into three groups based on treatment indications: AZO (n=34), DOR (n=34), and AZO+DOR (n=32). The patients' age, basal hormone levels (FSH, E2, PRG, AMH), treatment indications, embryo transfer days, and clinical pregnancy outcomes were documented.</div></div><div><h3>Results</h3><div>Clinical pregnancy rates were found to be 64.7% in the AZO group, 50% in the DOR group, and 34.4% in the DOR+AZO group. When the groups were compared among themselves, the clinical pregnancy rate in the AZO group was found to be significantly higher than in the DOR+AZO group (p=0.014). When comparing live birth rates among the groups, the live birth rate in the DOR+AZO group was found to be significantly lower than in the AZO group (p=0.022). When the types of pregnancies were examined among the groups, in the DOR group, pregnancies resulted in live births at a rate of 70.6% and in missed abortion at a rate of 29.4%.</div></div><div><h3>Conclusions</h3><div>Clinical pregnancy and live birth rates were found to be significantly higher in the AZO group compared to the DOR+AZO group. We believe that ovarian reserve in women is more determinant of IVF/ICSI success than sperm quality.</div></div>","PeriodicalId":21134,"journal":{"name":"Reproductive biomedicine online","volume":"49 ","pages":"Article 104590"},"PeriodicalIF":3.5000,"publicationDate":"2024-11-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"EFFECT OF OVARIAN RESERVE ON PREGNANCY OUTCOMES IN PATIENTS UNDERGOING IVF TREATMENT DUE TO AZOOSPERMIA\",\"authors\":\"Aycan Sıkı ,&nbsp;Can Köse ,&nbsp;Esin Kasap ,&nbsp;Ebru Şahin Güleç ,&nbsp;Ahmet Demir\",\"doi\":\"10.1016/j.rbmo.2024.104590\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objective</h3><div>Infertility is a condition that has been increasingly prevalent in recent years and has demographic, psychological, economic, and medical consequences in society. A review of the literature reveals a large number of studies conducted on azoospermia (AZO) and diminished ovarian reserve (DOR), but there are relatively few studies comparing these two conditions simultaneously. In our study, we aimed to contribute to the literature by comparing these two challenging groups that we treat in our clinic, both from the physician's and the patient's perspective.</div></div><div><h3>Materials and Methods</h3><div>In our study, patients diagnosed with azoospermia (AZO) and diminished ovarian reserve (DOR) who received intracytoplasmic sperm injection (ICSI) treatment at the Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, IVF Center, between January 1, 2017, and June 30, 2023, were examined. Within the inclusion and exclusion criteria, 100 cases were identified and divided into three groups based on treatment indications: AZO (n=34), DOR (n=34), and AZO+DOR (n=32). The patients' age, basal hormone levels (FSH, E2, PRG, AMH), treatment indications, embryo transfer days, and clinical pregnancy outcomes were documented.</div></div><div><h3>Results</h3><div>Clinical pregnancy rates were found to be 64.7% in the AZO group, 50% in the DOR group, and 34.4% in the DOR+AZO group. When the groups were compared among themselves, the clinical pregnancy rate in the AZO group was found to be significantly higher than in the DOR+AZO group (p=0.014). When comparing live birth rates among the groups, the live birth rate in the DOR+AZO group was found to be significantly lower than in the AZO group (p=0.022). When the types of pregnancies were examined among the groups, in the DOR group, pregnancies resulted in live births at a rate of 70.6% and in missed abortion at a rate of 29.4%.</div></div><div><h3>Conclusions</h3><div>Clinical pregnancy and live birth rates were found to be significantly higher in the AZO group compared to the DOR+AZO group. We believe that ovarian reserve in women is more determinant of IVF/ICSI success than sperm quality.</div></div>\",\"PeriodicalId\":21134,\"journal\":{\"name\":\"Reproductive biomedicine online\",\"volume\":\"49 \",\"pages\":\"Article 104590\"},\"PeriodicalIF\":3.5000,\"publicationDate\":\"2024-11-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Reproductive biomedicine online\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S147264832400779X\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"2024/12/4 0:00:00\",\"PubModel\":\"Epub\",\"JCR\":\"Q1\",\"JCRName\":\"OBSTETRICS & GYNECOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Reproductive biomedicine online","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S147264832400779X","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/12/4 0:00:00","PubModel":"Epub","JCR":"Q1","JCRName":"OBSTETRICS & GYNECOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

不孕不育是近年来越来越普遍的一种疾病,在社会上具有人口、心理、经济和医学后果。查阅文献发现,关于无精子症(AZO)和卵巢储备功能减退(DOR)的研究很多,但同时比较这两种情况的研究相对较少。在我们的研究中,我们的目的是通过比较我们在诊所治疗的这两个具有挑战性的群体,从医生和患者的角度来贡献文献。材料与方法本研究纳入2017年1月1日至2023年6月30日在Tepecik培训与研究医院IVF中心妇产科接受卵浆内单精子注射(ICSI)治疗的无精子症(AZO)和卵巢储备减退(DOR)患者。在纳入和排除标准内,确定100例病例,根据治疗适应证分为AZO组(n=34)、DOR组(n=34)和AZO+DOR组(n=32)。记录患者的年龄、基础激素水平(FSH、E2、PRG、AMH)、治疗指征、胚胎移植天数和临床妊娠结局。结果AZO组临床妊娠率为64.7%,DOR组为50%,DOR+AZO组为34.4%。两组间比较,AZO组临床妊娠率明显高于DOR+AZO组(p=0.014)。两组间活产率比较,DOR+AZO组活产率显著低于AZO组(p=0.022)。当检查各组之间的妊娠类型时,在DOR组中,妊娠导致活产率为70.6%,流产率为29.4%。结论AZO组临床妊娠率和活产率明显高于DOR+AZO组。我们认为女性卵巢储备比精子质量更能决定IVF/ICSI的成功。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
EFFECT OF OVARIAN RESERVE ON PREGNANCY OUTCOMES IN PATIENTS UNDERGOING IVF TREATMENT DUE TO AZOOSPERMIA

Objective

Infertility is a condition that has been increasingly prevalent in recent years and has demographic, psychological, economic, and medical consequences in society. A review of the literature reveals a large number of studies conducted on azoospermia (AZO) and diminished ovarian reserve (DOR), but there are relatively few studies comparing these two conditions simultaneously. In our study, we aimed to contribute to the literature by comparing these two challenging groups that we treat in our clinic, both from the physician's and the patient's perspective.

Materials and Methods

In our study, patients diagnosed with azoospermia (AZO) and diminished ovarian reserve (DOR) who received intracytoplasmic sperm injection (ICSI) treatment at the Tepecik Training and Research Hospital, Department of Obstetrics and Gynecology, IVF Center, between January 1, 2017, and June 30, 2023, were examined. Within the inclusion and exclusion criteria, 100 cases were identified and divided into three groups based on treatment indications: AZO (n=34), DOR (n=34), and AZO+DOR (n=32). The patients' age, basal hormone levels (FSH, E2, PRG, AMH), treatment indications, embryo transfer days, and clinical pregnancy outcomes were documented.

Results

Clinical pregnancy rates were found to be 64.7% in the AZO group, 50% in the DOR group, and 34.4% in the DOR+AZO group. When the groups were compared among themselves, the clinical pregnancy rate in the AZO group was found to be significantly higher than in the DOR+AZO group (p=0.014). When comparing live birth rates among the groups, the live birth rate in the DOR+AZO group was found to be significantly lower than in the AZO group (p=0.022). When the types of pregnancies were examined among the groups, in the DOR group, pregnancies resulted in live births at a rate of 70.6% and in missed abortion at a rate of 29.4%.

Conclusions

Clinical pregnancy and live birth rates were found to be significantly higher in the AZO group compared to the DOR+AZO group. We believe that ovarian reserve in women is more determinant of IVF/ICSI success than sperm quality.
求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Reproductive biomedicine online
Reproductive biomedicine online 医学-妇产科学
CiteScore
7.20
自引率
7.50%
发文量
391
审稿时长
50 days
期刊介绍: Reproductive BioMedicine Online covers the formation, growth and differentiation of the human embryo. It is intended to bring to public attention new research on biological and clinical research on human reproduction and the human embryo including relevant studies on animals. It is published by a group of scientists and clinicians working in these fields of study. Its audience comprises researchers, clinicians, practitioners, academics and patients. Context: The period of human embryonic growth covered is between the formation of the primordial germ cells in the fetus until mid-pregnancy. High quality research on lower animals is included if it helps to clarify the human situation. Studies progressing to birth and later are published if they have a direct bearing on events in the earlier stages of pregnancy.
期刊最新文献
Back to the future! Is there still a role for the GnRH agonist protocol in ovarian stimulation? L-carnitine ameliorates decidualization in high-fat diet-induced obese rats and human endometrial stromal cells treated with palmitic acid Decidual senescence in recurrent pregnancy loss: forkhead box M1-targeted progesterone treatment Electroacupuncture alleviates endometriosis by suppressing ferroptosis in murine ectopic and eutopic endometria via the Nrf2 pathway Polarized light microscopy reveals distinct spindle phenotypes and outcomes in non-pronuclear zygotes
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1